Invion Ltd
Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme, lung, and ovarian cancers; and human papilloma virus. It is also in… Read more
Invion Ltd (IVX) - Net Assets
Latest net assets as of June 2025: AU$8.25 Million AUD
Based on the latest financial reports, Invion Ltd (IVX) has net assets worth AU$8.25 Million AUD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$9.49 Million) and total liabilities (AU$1.24 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$8.25 Million |
| % of Total Assets | 86.95% |
| Annual Growth Rate | 24.86% |
| 5-Year Change | 72.23% |
| 10-Year Change | 37.77% |
| Growth Volatility | 229.29 |
Invion Ltd - Net Assets Trend (2001–2025)
This chart illustrates how Invion Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Invion Ltd (2001–2025)
The table below shows the annual net assets of Invion Ltd from 2001 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$8.25 Million | -42.85% |
| 2024-06-30 | AU$14.44 Million | -21.52% |
| 2023-06-30 | AU$18.40 Million | -6.04% |
| 2022-06-30 | AU$19.58 Million | +308.69% |
| 2021-06-30 | AU$4.79 Million | -11.84% |
| 2020-06-30 | AU$5.43 Million | -0.43% |
| 2019-06-30 | AU$5.46 Million | -30.98% |
| 2018-06-30 | AU$7.91 Million | +97.30% |
| 2017-06-30 | AU$4.01 Million | -33.09% |
| 2016-06-30 | AU$5.99 Million | -12.70% |
| 2015-06-30 | AU$6.86 Million | -32.47% |
| 2014-06-30 | AU$10.16 Million | -7.94% |
| 2013-06-30 | AU$11.04 Million | +83.52% |
| 2012-06-30 | AU$6.01 Million | +380.68% |
| 2011-06-30 | AU$-2.14 Million | +55.15% |
| 2010-06-30 | AU$-4.78 Million | -139.35% |
| 2009-06-30 | AU$12.14 Million | +476.35% |
| 2008-06-30 | AU$-3.23 Million | -550.92% |
| 2007-06-30 | AU$715.28K | -85.20% |
| 2006-06-30 | AU$4.83 Million | +152.31% |
| 2005-06-30 | AU$1.92 Million | +224.20% |
| 2004-06-30 | AU$591.00K | +11.72% |
| 2003-06-30 | AU$529.00K | +302.68% |
| 2002-06-30 | AU$-261.00K | -752.50% |
| 2001-06-30 | AU$40.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Invion Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 14454139000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$151.21 Million | 1832.64% |
| Other Comprehensive Income | AU$1.59 Million | 19.21% |
| Total Equity | AU$8.25 Million | 100.00% |
Invion Ltd Competitors by Market Cap
The table below lists competitors of Invion Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PIPER JAFFRAY (PJR.SG)
STU:PJR
|
$2.48 Million |
|
MPAY S.A. ZY-50
F:8NJ
|
$2.48 Million |
|
G1 Secure Solutions Ltd
TA:GOSS
|
$2.48 Million |
|
ASI Aviation Inc
PINK:ASAV
|
$2.48 Million |
|
NAYA Biosciences, Inc
NASDAQ:NAYA
|
$2.48 Million |
|
FTI Foodtech International Inc
V:FTI
|
$2.48 Million |
|
Beonic Ltd
AU:BEO
|
$2.48 Million |
|
Sabvest Capital Ltd
JSE:SBP
|
$2.48 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Invion Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 14,437,672 to 8,250,750, a change of -6,186,922 (-42.9%).
- Net loss of 8,807,732 reduced equity.
- Share repurchases of 170,302 reduced equity.
- New share issuances of 3,950,400 increased equity.
- Other comprehensive income decreased equity by 577,889.
- Other factors decreased equity by 581,399.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-8.81 Million | -106.75% |
| Share Repurchases | AU$170.30K | -2.06% |
| Share Issuances | AU$3.95 Million | +47.88% |
| Other Comprehensive Income | AU$-577.89K | -7.0% |
| Other Changes | AU$-581.40K | -7.05% |
| Total Change | AU$- | -42.85% |
Book Value vs Market Value Analysis
This analysis compares Invion Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.67x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.01x to 0.67x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-06-30 | AU$7.41 | AU$0.08 | x |
| 2007-06-30 | AU$1.86 | AU$0.08 | x |
| 2008-06-30 | AU$-7.59 | AU$0.08 | x |
| 2009-06-30 | AU$0.10 | AU$0.08 | x |
| 2010-06-30 | AU$-4.77 | AU$0.08 | x |
| 2011-06-30 | AU$-1.22 | AU$0.08 | x |
| 2012-06-30 | AU$1.99 | AU$0.08 | x |
| 2013-06-30 | AU$2.15 | AU$0.08 | x |
| 2014-06-30 | AU$1.48 | AU$0.08 | x |
| 2015-06-30 | AU$0.89 | AU$0.08 | x |
| 2016-06-30 | AU$0.44 | AU$0.08 | x |
| 2017-06-30 | AU$0.25 | AU$0.08 | x |
| 2018-06-30 | AU$0.21 | AU$0.08 | x |
| 2019-06-30 | AU$0.00 | AU$0.08 | x |
| 2020-06-30 | AU$0.00 | AU$0.08 | x |
| 2021-06-30 | AU$0.00 | AU$0.08 | x |
| 2022-06-30 | AU$0.32 | AU$0.08 | x |
| 2023-06-30 | AU$0.29 | AU$0.08 | x |
| 2024-06-30 | AU$0.22 | AU$0.08 | x |
| 2025-06-30 | AU$0.11 | AU$0.08 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Invion Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -106.75%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.15x
- Recent ROE (-106.75%) is above the historical average (-185.79%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | -476.78% | -260.35% | 0.33x | 5.57x | AU$-12.20 Million |
| 2007 | -2254.35% | 0.00% | 0.00x | 5.22x | AU$-16.20 Million |
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | AU$-20.69 Million |
| 2010 | 0.00% | -11990.85% | 0.03x | 0.00x | AU$-16.31 Million |
| 2011 | 0.00% | -9566.43% | 0.03x | 0.00x | AU$-13.47 Million |
| 2012 | -92.15% | -5957.98% | 0.01x | 1.14x | AU$-6.14 Million |
| 2013 | -46.89% | 0.00% | 0.00x | 1.47x | AU$-6.28 Million |
| 2014 | -67.76% | -3320.17% | 0.01x | 1.45x | AU$-7.90 Million |
| 2015 | -190.10% | -7035.81% | 0.01x | 2.35x | AU$-13.73 Million |
| 2016 | -74.27% | -3197.49% | 0.01x | 2.00x | AU$-5.05 Million |
| 2017 | -54.89% | 0.00% | 0.00x | 1.45x | AU$-2.60 Million |
| 2018 | -11.72% | -125.59% | 0.07x | 1.31x | AU$-1.72 Million |
| 2019 | -46.66% | -65.59% | 0.64x | 1.11x | AU$-3.09 Million |
| 2020 | -17.55% | -27.44% | 0.60x | 1.06x | AU$-1.50 Million |
| 2021 | -30.96% | -63.65% | 0.41x | 1.18x | AU$-1.96 Million |
| 2022 | -11.45% | -68.09% | 0.16x | 1.02x | AU$-4.20 Million |
| 2023 | -8.78% | -39.34% | 0.22x | 1.04x | AU$-3.45 Million |
| 2024 | -38.98% | -152.34% | 0.24x | 1.07x | AU$-7.07 Million |
| 2025 | -106.75% | 0.00% | 0.00x | 1.15x | AU$-9.63 Million |
Industry Comparison
This section compares Invion Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $19,218,986
- Average return on equity (ROE) among peers: -164.87%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Invion Ltd (IVX) | AU$8.25 Million | -476.78% | 0.15x | $2.48 Million |
| Aft Pharmaceuticals Ltd (AFP) | $28.23 Million | -47.00% | 1.31x | $53.97 Million |
| Althea Group Holdings Ltd (AGH) | $42.70 Million | -35.24% | 0.26x | $6.03 Million |
| BOD Science Ltd (BOD) | $3.47 Million | -155.95% | 0.53x | $1.38 Million |
| BPH Global Ltd (BP8) | $-1.46 Million | 0.00% | 0.00x | $781.31K |
| Cann Group Ltd (CAN) | $-2.77 Million | 0.00% | 0.00x | $2.39 Million |
| ECS Botanics Holdings Ltd (ECS) | $188.48K | -116.04% | 0.13x | $2.73 Million |
| IDT Australia Ltd (IDT) | $25.01 Million | -24.32% | 0.25x | $8.48 Million |
| Little Green Pharma Ltd (LGP) | $77.26 Million | -10.55% | 0.12x | $14.26 Million |
| Live Verdure Ltd (LV1) | $362.12K | -1094.69% | 2.55x | $28.27 Million |